4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile Inhibitors of Epidermal Growth Factor Receptor Kinase and Their Bioisosteric Relationship to the 4-Anilino-6,7-dialkoxyquinazoline Inhibitors
Allan Wissner
1
,
Dan M Berger
1
,
Diane H Boschelli
1
,
M.Brawner Floyd
1
,
Lee M. Greenberger
1
,
Brian C Gruber
1
,
Bernard D Johnson
1
,
Nellie Mamuya
1
,
Ramaswamy Nilakantan
1
,
Marvin F Reich
1
,
SHEN RU
1
,
Hwei-Ru Tsou
1
,
Erik Upeslacis
1
,
Yu-Fen Wang
1
,
Biqi Wu
1
,
Fei Ye
1
,
Nan Zhang
1
1
Wyeth-Ayerst Research, A Division of American Home Products, 401 North Middletown Road, Pearl River, New York 10965-1215
|
Publication type: Journal Article
Publication date: 2000-08-01
scimago Q1
wos Q1
SJR: 1.801
CiteScore: 11.5
Impact factor: 6.8
ISSN: 00222623, 15204804
PubMed ID:
10966743
Drug Discovery
Molecular Medicine
Abstract
The synthesis and SAR of a series of 4-anilino-6, 7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor (EGF-R) kinase are described. Condensation of 3, 4-dialkoxyanilines with ethyl (ethoxymethylene)cyanoacetate followed by thermal cyclization gave, regiospecifically, 6,7-dialkoxy-4-oxo-1, 4-dihydroquinoline-3-carbonitriles. Chlorination (POCl(3)) followed by the reaction with substituted anilines furnished the 4-anilino-6, 7-dialkoxyquinoline-3-carbonitrile inhibitors of EGF-R kinase. An alternate synthesis of these compounds starts with a methyl 3, 4-dialkoxybenzoate. Nitration followed by reduction (Fe, NH(4)Cl, MeOH-H(2)O) gave a methyl 2-amino-4,5-dialkoxybenzoate. Amidine formation using DMF-acetal followed by cyclization using LiCH(2)CN furnished a 6,7-dialkoxy-4-oxo-1,4-dihydroquinoline-3-carbonitrile, which was transformed as before. Compounds containing acid, ester, amide, carbinol, and aldehyde groups at the 3-position of the quinoline ring were also prepared for comparison, as were several 1-anilino-6,7-dimethoxyisoquinoline-4-carbonitriles. The compounds were evaluated for their ability to inhibit the autophosphorylation of the catalytic domain of EGF-R. The SAR of these inhibitors with respect to the nature of the 6,7-alkoxy groups, the aniline substituents, and the substituent at the 3-position was studied. The compounds were further evaluated for their ability to inhibit the growth of cell lines that overexpress EGF-R or HER-2. It was found that 4-anilinoquinoline-3-carbonitriles are effective inhibitors of EGF-R kinase with activity comparable to the 4-anilinoquinazoline-based inhibitors. A new homology model of EGF-R kinase was constructed based on the X-ray structures of Hck and FGF receptor-1 kinase. The model suggests that with the quinazoline-based inhibitors, the N3 atom is hydrogen-bonded to a water molecule which, in turn, interacts with Thr 830. It is proposed that the quinoline-3-carbonitriles bind in a similar manner where the water molecule is displaced by the cyano group which interacts with the same Thr residue.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
14
16
18
|
|
|
Bioorganic and Medicinal Chemistry Letters
18 publications, 10.06%
|
|
|
Journal of Medicinal Chemistry
15 publications, 8.38%
|
|
|
Bioorganic and Medicinal Chemistry
10 publications, 5.59%
|
|
|
European Journal of Medicinal Chemistry
7 publications, 3.91%
|
|
|
Molecules
6 publications, 3.35%
|
|
|
Journal of Chemical Information and Modeling
5 publications, 2.79%
|
|
|
Bioorganic Chemistry
4 publications, 2.23%
|
|
|
ChemMedChem
4 publications, 2.23%
|
|
|
Archiv der Pharmazie
4 publications, 2.23%
|
|
|
Journal of the American Chemical Society
3 publications, 1.68%
|
|
|
Medicinal Chemistry Research
3 publications, 1.68%
|
|
|
Journal of Heterocyclic Chemistry
3 publications, 1.68%
|
|
|
Physical Chemistry Chemical Physics
3 publications, 1.68%
|
|
|
Current Medicinal Chemistry
2 publications, 1.12%
|
|
|
Chinese Chemical Letters
2 publications, 1.12%
|
|
|
Polyhedron
2 publications, 1.12%
|
|
|
Tetrahedron Letters
2 publications, 1.12%
|
|
|
Chemistry and Biodiversity
2 publications, 1.12%
|
|
|
Chemical Biology and Drug Design
2 publications, 1.12%
|
|
|
Biochemistry
2 publications, 1.12%
|
|
|
New Journal of Chemistry
2 publications, 1.12%
|
|
|
RSC Advances
2 publications, 1.12%
|
|
|
Journal of Enzyme Inhibition and Medicinal Chemistry
2 publications, 1.12%
|
|
|
Chemical Reviews
1 publication, 0.56%
|
|
|
Journal of Chemical Information and Computer Sciences
1 publication, 0.56%
|
|
|
Journal of Physical Chemistry B
1 publication, 0.56%
|
|
|
Current Organic Chemistry
1 publication, 0.56%
|
|
|
Drug Discovery Today
1 publication, 0.56%
|
|
|
Pharmacology and Therapeutics
1 publication, 0.56%
|
|
|
2
4
6
8
10
12
14
16
18
|
Publishers
|
10
20
30
40
50
60
70
|
|
|
Elsevier
61 publications, 34.08%
|
|
|
American Chemical Society (ACS)
32 publications, 17.88%
|
|
|
Wiley
31 publications, 17.32%
|
|
|
Springer Nature
16 publications, 8.94%
|
|
|
Royal Society of Chemistry (RSC)
11 publications, 6.15%
|
|
|
MDPI
8 publications, 4.47%
|
|
|
Taylor & Francis
7 publications, 3.91%
|
|
|
Bentham Science Publishers Ltd.
3 publications, 1.68%
|
|
|
American Society for Biochemistry and Molecular Biology
1 publication, 0.56%
|
|
|
Mary Ann Liebert
1 publication, 0.56%
|
|
|
Pharmaceutical Society of Japan
1 publication, 0.56%
|
|
|
Public Library of Science (PLoS)
1 publication, 0.56%
|
|
|
Hindawi Limited
1 publication, 0.56%
|
|
|
American Association for Cancer Research (AACR)
1 publication, 0.56%
|
|
|
Cambridge University Press
1 publication, 0.56%
|
|
|
Georg Thieme Verlag KG
1 publication, 0.56%
|
|
|
Frontiers Media S.A.
1 publication, 0.56%
|
|
|
10
20
30
40
50
60
70
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
179
Total citations:
179
Citations from 2024:
15
(8.38%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Wissner A. et al. 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile Inhibitors of Epidermal Growth Factor Receptor Kinase and Their Bioisosteric Relationship to the 4-Anilino-6,7-dialkoxyquinazoline Inhibitors // Journal of Medicinal Chemistry. 2000. Vol. 43. No. 17. pp. 3244-3256.
GOST all authors (up to 50)
Copy
Wissner A., Berger D. M., Boschelli D. H., Floyd M., Greenberger L. M., Gruber B. C., Johnson B. D., Mamuya N., Nilakantan R., Reich M. F., RU S., Tsou H., Upeslacis E., Wang Y., Wu B., Ye F., Zhang N. 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile Inhibitors of Epidermal Growth Factor Receptor Kinase and Their Bioisosteric Relationship to the 4-Anilino-6,7-dialkoxyquinazoline Inhibitors // Journal of Medicinal Chemistry. 2000. Vol. 43. No. 17. pp. 3244-3256.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1021/jm000206a
UR - https://doi.org/10.1021/jm000206a
TI - 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile Inhibitors of Epidermal Growth Factor Receptor Kinase and Their Bioisosteric Relationship to the 4-Anilino-6,7-dialkoxyquinazoline Inhibitors
T2 - Journal of Medicinal Chemistry
AU - Wissner, Allan
AU - Berger, Dan M
AU - Boschelli, Diane H
AU - Floyd, M.Brawner
AU - Greenberger, Lee M.
AU - Gruber, Brian C
AU - Johnson, Bernard D
AU - Mamuya, Nellie
AU - Nilakantan, Ramaswamy
AU - Reich, Marvin F
AU - RU, SHEN
AU - Tsou, Hwei-Ru
AU - Upeslacis, Erik
AU - Wang, Yu-Fen
AU - Wu, Biqi
AU - Ye, Fei
AU - Zhang, Nan
PY - 2000
DA - 2000/08/01
PB - American Chemical Society (ACS)
SP - 3244-3256
IS - 17
VL - 43
PMID - 10966743
SN - 0022-2623
SN - 1520-4804
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2000_Wissner,
author = {Allan Wissner and Dan M Berger and Diane H Boschelli and M.Brawner Floyd and Lee M. Greenberger and Brian C Gruber and Bernard D Johnson and Nellie Mamuya and Ramaswamy Nilakantan and Marvin F Reich and SHEN RU and Hwei-Ru Tsou and Erik Upeslacis and Yu-Fen Wang and Biqi Wu and Fei Ye and Nan Zhang},
title = {4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile Inhibitors of Epidermal Growth Factor Receptor Kinase and Their Bioisosteric Relationship to the 4-Anilino-6,7-dialkoxyquinazoline Inhibitors},
journal = {Journal of Medicinal Chemistry},
year = {2000},
volume = {43},
publisher = {American Chemical Society (ACS)},
month = {aug},
url = {https://doi.org/10.1021/jm000206a},
number = {17},
pages = {3244--3256},
doi = {10.1021/jm000206a}
}
Cite this
MLA
Copy
Wissner, Allan, et al. “4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile Inhibitors of Epidermal Growth Factor Receptor Kinase and Their Bioisosteric Relationship to the 4-Anilino-6,7-dialkoxyquinazoline Inhibitors.” Journal of Medicinal Chemistry, vol. 43, no. 17, Aug. 2000, pp. 3244-3256. https://doi.org/10.1021/jm000206a.